Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers-Reference-Cited by-同舟云学术

Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers

Published:2018-03-17 Issue:9 Volume:30 Page:419-428
ISSN:0953-8178
Container-title:International Immunology
language:en
Short-container-title:

Author:

Nomura Takashi¹,Honda Tetsuya¹,Kabashima Kenji¹²

Affiliation:

1. Department of Dermatology, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8326, Japan

2. Singapore Immunology Network (SIgN) and Institute of Medical Biology (IMB), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore

Funder

Japan Society for the Promotion of Science

Japan Science and Technology Agency

Precursory Research for Embryonic Science and Technology

Japan Agency for Medical Research and Development

Publisher

Oxford University Press (OUP)

Subject

Immunology,General Medicine,Immunology and Allergy

Link

http://academic.oup.com/intimm/article-pdf/30/9/419/25627964/dxy015.pdf

Reference84 articles.

1. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity;Kabashima;J. Dermatol. Sci,2013

2. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients;Wollenberg;J. Eur. Acad. Dermatol. Venereol,2016

3. Atopic dermatitis;Weidinger;Lancet,2016

4. Japanese guidelines for atopic dermatitis 2017;Katayama;Allergol. Int,2017

5. Filaggrin mutations and atopy: consequences for future therapeutics;Heimall;Expert Rev. Clin. Immunol,2012

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement effects of tapinarof on the skin barrier function in Japanese patients with atopic dermatitis;Journal of Cutaneous Immunology and Allergy;2024-08-06

2. Integrating multi‐omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directions;Allergy;2024-06-04

3. A quantitative systems pharmacology workflow toward optimal design and biomarker stratification of atopic dermatitis clinical trials;Journal of Allergy and Clinical Immunology;2024-05

4. A placebo‐controlled, double‐blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs;Veterinary Dermatology;2024-03-11

5. Canine Atopic Dermatitis: Prevalence, Impact, and Management Strategies;Veterinary Medicine: Research and Reports;2024-02